Cite
HARVARD Citation
Hall, S. et al. (2022). Stopping nucleot(s)ide analogues in non‐cirrhotic HBeAg‐negative chronic hepatitis B patients: HBsAg loss at 96 weeks is associated with low baseline HBsAg levels. Alimentary pharmacology & therapeutics. 56 (2), pp. 310-320. [Online].